Smart deals start with the right connections.
Access 800+ qualified LPs through CQ’s Investor Database.
Overview and Management
Establishment Year
1987
Mission
Our mission is to bridge the gap between cutting-edge research and the commercial sphere, ensuring innovative cancer treatments reach patients.
Values
Patient focus, Innovation, Long-term perspective, Collaboration
Investment Roles
Direct Investor,General Partner (GP)
Participant Demographics
Serves cancer patients globally, supports research institutions, and collaborates with private enterprises.
Generational Wealth Planning
Risk Tolerance
High; embraces risk and prioritizes groundbreaking innovations over incremental improvements.
References or Case Studies
Can provide examples of portfolio companies and divestments.
Team Experience
Notable Achievements
Participated in nine IPOs and allocated NOK 237 million to cancer research.
Project Track Record
Investments in innovative companies like Nykode, Ultimovacs, Zelluna, among others.
Exit Strategies
Strategic sales, IPOs.
Legal, Compliance and Contact Information
Regulatory Registrations
Compliance History
at@radforsk.no
Phone Number
Address
Oslo Norway